The federal agency has issued a rule that will end Medicaid coverage for gender-affirming hormone therapies and procedures for children under 18. The change means that children who previously received coverage for these treatments will no longer be eligible under Medicaid. The rule was announced by the Centers for Medicare and Medicaid Services and was reported by Colorado Newsline. The decision affects families and providers who rely on Medicaid to cover gender-affirming care for minors.
Sources: Colorado Newsline (nonprofit statehouse newsroom)
